Biomarkers of Trastuzumab-Induced Cardiac Toxicity in HER2- Positive Breast Cancer Patient Population

SIMPLE SUMMARY: Trastuzumab administered as a (neo)adjuvant therapy in radically treated Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer patients improves overall survival. This study aimed to assess if factors commonly thought to play a role as biomarkers of trastuzumab-induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Grela-Wojewoda, Aleksandra, Püsküllüoğlu, Mirosława, Sas-Korczyńska, Beata, Zemełka, Tomasz, Pacholczak-Madej, Renata, Wysocki, Wojciech M., Wojewoda, Tomasz, Adamczyk, Agnieszka, Lompart, Joanna, Korman, Michał, Mucha-Małecka, Anna, Ziobro, Marek, Konduracka, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313458/
https://www.ncbi.nlm.nih.gov/pubmed/35884413
http://dx.doi.org/10.3390/cancers14143353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313458/
https://www.ncbi.nlm.nih.gov/pubmed/35884413
http://dx.doi.org/10.3390/cancers14143353

Ejemplares similares